0001437749-24-004259.txt : 20240214
0001437749-24-004259.hdr.sgml : 20240214
20240214215350
ACCESSION NUMBER: 0001437749-24-004259
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Power Sean A
CENTRAL INDEX KEY: 0001538845
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 24641859
MAIL ADDRESS:
STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
5
1
rdgdoc.xml
FORM 5
X0508
5
2024-02-14
0
1
0001001316
TG THERAPEUTICS, INC.
TGTX
0001538845
Power Sean A
3020 CARRINGTON MILL BLVD
SUITE 475
MORRISVILLE
NC
27560
1
CFO
0
Common Stock
2023-12-15
4
G
0
L
40000
0
D
641969
D
Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust.
/s/ Sean A. Power
2024-02-14